Morgan Rosel Wealth Management, LLC Recursion Pharmaceuticals, Inc. Transaction History
Morgan Rosel Wealth Management, LLC
- $313 Million
- Q1 2025
A detailed history of Morgan Rosel Wealth Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Rosel Wealth Management, LLC holds 77 shares of RXRX stock, worth $441. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77Holding current value
$441% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
348Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$195 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$185 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$142 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$99.2 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$84 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.03B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...